What treatment options are available for constant burning and aching sensations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Constant Burning and Aching Sensations

For constant burning and aching pain, start with gabapentin 100-300 mg at bedtime, titrating up to 900-3600 mg daily in divided doses, as this is the first-line pharmacological treatment for neuropathic pain with the strongest evidence base. 1

Initial Assessment and Pain Characterization

Before initiating treatment, determine if the burning and aching sensations are:

  • Neuropathic in origin (sharp, tingling, shooting, burning quality suggesting nerve damage) 1
  • Localized or widespread (affects treatment selection between topical vs systemic agents) 1
  • Associated with specific conditions (postherpetic neuralgia, diabetic neuropathy, cancer-related pain) 1

First-Line Pharmacological Treatment: Gabapentinoids

Gabapentin Dosing Protocol

  • Start low: Begin with 100-300 mg once daily at bedtime (use 100 mg in elderly or renally impaired patients) 1, 2
  • Titrate gradually: Increase by 100-300 mg every 3-5 days as tolerated 1
  • Target dose: 900-1800 mg daily divided into 2-3 doses provides substantial benefit for most patients 1, 2, 3
  • Maximum dose: Up to 3600 mg daily in divided doses may be needed for refractory cases 1, 2, 3
  • Evidence: 32-38% of patients achieve at least 50% pain relief compared to 17-21% with placebo (NNT 5.9-6.7) 3

Pregabalin as Alternative

If gabapentin is not tolerated or ineffective:

  • Start: 25-50 mg daily (lower dose for elderly or renal impairment) 1
  • Titrate: Increase every 3-5 days 1
  • Target dose: 150-300 mg daily in 2 divided doses 1
  • Maximum: 600 mg daily 1, 4
  • Advantage: More predictable absorption and easier titration than gabapentin 1

Common side effects to monitor: Somnolence (14%), dizziness (19%), peripheral edema (7%), gait disturbance (14%) - typically mild to moderate and subside within 10 days 2, 3

Second-Line Options if Inadequate Response to Gabapentinoids

Antidepressants

Tricyclic antidepressants (if no cardiac contraindications):

  • Nortriptyline or desipramine preferred (better tolerated than amitriptyline) 1
  • Start: 10-25 mg nightly 1
  • Titrate: Increase every 3-5 days up to 14 days 1
  • Target: 50-150 mg nightly 1

SNRIs (serotonin-norepinephrine reuptake inhibitors):

  • Duloxetine: Start 30-60 mg daily 1
  • Venlafaxine: Start 50-75 mg daily, increase to 75-225 mg daily 1

Topical Treatments for Localized Pain

First-Line Topical Agents

Lidocaine 5% patch:

  • Apply daily to painful site 1, 5, 6
  • Minimal systemic absorption, excellent safety profile 1, 5
  • Can cut patches to fit affected area, use up to 3 patches simultaneously 6

High-concentration capsaicin (8% patch):

  • Single 30-minute application provides relief for up to 12 weeks 1
  • Apply 4% lidocaine for 60 minutes before capsaicin to reduce initial burning 1
  • Expect initial burning/stinging that subsides with continued use 6

Topical NSAIDs (diclofenac gel/patch):

  • Apply 3 times daily for inflammatory pain 1, 5, 6
  • Preferred in elderly due to reduced systemic adverse effects 1, 5

Combination Therapy Approach

When monotherapy provides insufficient relief:

  • Combine gabapentinoid with topical agent (lidocaine patch or capsaicin) 1, 5
  • Add antidepressant to gabapentinoid for synergistic effect 1
  • Consider alpha lipoic acid 600 mg daily as adjunct (particularly for neuropathic pain) 1

Non-Pharmacological Interventions

Cognitive behavioral therapy: Strongly recommended for chronic pain management, promotes adaptive behaviors and addresses maladaptive pain responses 1

Physical therapy: Recommended for maintaining function and reducing pain 1

Hypnosis: Specifically recommended for neuropathic pain 1

Special Considerations and Pitfalls

Renal Impairment

  • Dose adjustment mandatory for gabapentin and pregabalin in patients with creatinine clearance <60 mL/min 1, 4
  • Patients with CrCl 30-60 mL/min tolerate gabapentinoids less well with higher discontinuation rates 4

Elderly Patients

  • Start with lowest doses: Gabapentin 100-200 mg/day or pregabalin 25-50 mg/day 1
  • Slower titration: Extend intervals between dose increases 1
  • Monitor closely: Higher risk of somnolence, dizziness, mental clouding 1

Avoid Common Mistakes

  • Do not start gabapentin at 300 mg three times daily - this causes excessive side effects and poor adherence 1, 2
  • Do not discontinue prematurely - analgesic effect may take 1-2 weeks to manifest fully 2, 3
  • Do not use lamotrigine - proven ineffective for neuropathic pain 1
  • Do not use neuroleptics - limited efficacy with significant adverse effects in older adults 1

Treatment Timeline

  • Week 1: Pain relief may begin as early as first week 4, 2
  • Weeks 2-4: Continue titration until benefit occurs or side effects limit further increase 1
  • Reassess at 4-8 weeks: If inadequate response, add second agent or switch to alternative 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Guideline

Alternatives to Diclofenac Gel for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Topical Treatments for Neck Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.